Dyadic
About Dyadic
Investor Information
News and Media
Careers
Technology Platform
Genomic Products & Services
Enzymes
Manufacturing Services






Investor Presentation
January 2012
The Power of Proteins
Read more
Article in Renewable Energy Magazine
August 2011
Green Sugars™, the Next Oil
Read more
Article in Biofuels Journal
June 2011
Bioenzyme For Biofuels
Read more
The World Conference on Industrial Biotechnology and Bioprocessing Conference Presentation
May 11, 2011
Efficient Saccharification of Lignocellulosic Feedstocks Using the C1-Technology Platform
Read more
Advance Biofuels Leadership Conference Presentation
April 20, 2011
Continuing Enzymatic Enhancements
Read more
Biofuels International
March 2011
Easy to Digest Enzymes
Read more
Presentation at World Biofuels Markets 2011
March 24, 2011
The C1 technology platform - Facilitating the economic production of lignocellulose based biofuels and chemicals
Read more
Presentation at World Biofuels Markets 2011
March 23, 2011
Cost efficient production of fuels and chemicals based on lignocellulose
Read more
Presentation at Renewable Fuels Association 16th Annual National Ethanol Conference
February 20-22, 2011
Building Bridges To A More Sustainable Future
Read more
Dyadic International, Inc. Presents at Rodman & Renshaw
September 2010
Read more
EnGen Bio Presents at Rodman & Renshaw
September 2010
Read more
Treasure Coast Business Journal
August 2010
Mark Emalfarb of Dyadic International - R&D Powerhouses Never Gives Up
Read more
The Palm Beach Post Money
December 2009
Best, worst performers of 2009 for Palm Beach County and Treasure Coast
Read more
TCPalm.com
November 2009
Future is sweet for Jupiter CEO
Read more
RENEWABLE ENERGY MAGAZINE
October 2009
INTERVIEW: Mark Emalfarb, CEO of biofuel innovator, Dyadic International
Read more
Florida Trend
September 2009
A Matter of Chemistry
Read more
Interviews of Mark Emalfarb at the Sixth Annual World Congress on Industrial Biotechnology & Bioprocessing
August 2009
View Video
South Florida Business Journal
May 2009
Dyadic CEO Makes A Comeback, Company sues prominent legal and accounting firms
Read more
Ethanol Producer Magazine
January 2007
Enabling the Biorefinery Concept
Read more
Ethanol Producer Magazine
January 2007
The Discoverer's Game
Read more
BusinessWeek
December 2006
Put A Termite In Your Tank
Read more
Nature [registration required]
Vol. 444, 7 December 2006
A Field in Ferment
Read more
Entrepreneur
December 2006
Dyadic Snapshot -- Good Genes
Read more
Chicago Tribune
October 13, 2006
Beyond corn: Ethanol's next generation:
Scientists seek cheap, plentiful energy alternatives

Read more
Ethanol Today
October 2006
Cellulosic Ethanol: Harvesting the Potential
Read more
Distillers Grains Quarterly
Fall 2006
Coproduct Breakdown
Read more
Society for Industrial Microbiology Annual Industrial Microbiology and Biotechnology Meeting
August 1, 2006
Presentation by Richard Burlingame, Ph.D.
Read more

U.S. Department of Agriculture
2006
Ethanol Production from Alkaline Peroxide Pretreated Enzymatically Saccharified Wheat Straw
Read more

BioPharm International
May 1, 2006
Maximizing Protein Expression in Filamentous Fungi
Read more

ETHANOL: DOE lays out research plan for cellulosic fuel production
Read Press Release
Breaking the Biological Barriers to Cellulosic Ethanol: A Joint Research Agenda (Full Report)
For information regarding News and Media please contact investors@dyadic.com


 
Dyadic Netherlands Joins Kluyver Centre's Industrial Platform

Wageningen, The Netherlands

November 10, 2009

Dyadic Nederland BV (“Dyadic Netherlands”), the research and development arm of Dyadic International, Inc. (Pink Sheets: DYAI)(“Dyadic”) announced today that it has joined the Industrial Platform of the Kluyver Centre for Genomics of Industrial Fermentation (the “Kluyver Centre”). This platform consists of both small to medium enterprise companies and multinationals involved in the field of industrial fermentation. Industrial Platform members link to the Kluyver Centre and benefit from direct, confidential access to results from the Kluyver Centre’s pre-commercialisation research activities. Membership will also enable Dyadic Netherlands to rapidly access an extended network of world class scientists.

By joining the Kluyver Centre’s Industrial Platform, Dyadic Netherlands will be actively involved in the Kluyver Centre’s research program entitled, “Filamentous Fungi for Proteins and Peptides,” but also intends to contribute to the centre by their experience in genomics of industrially relevant fungal strains. Jan Wery, Director Research and Development of Dyadic Netherlands stated: “As genomics research has become pivotal for the development of cutting edge enzyme technology at Dyadic, it is very important for us to stay connected to the state-of-the-art developments in this area. The Kluyver Centre is one of the outstanding consortia and provides this research and knowledge.” Wim van der Wilden, General Manager of Dyadic Netherlands added: “Our participation in the Kluyver Centre, in conjunction with our involvement in different European consortia such as the Eurofung Network, will support our goal of strengthening the position of Dyadic Netherlands in the Dutch biotech sector as well as the broader international biotech arena.”

About Dyadic Netherlands and Dyadic
Dyadic Netherlands is a wholly owned subsidiary of Dyadic based in Wageningen, the Netherlands that is dedicated to research and development activities for the benefit of Dyadic, its collaborators and customers. Please visit Dyadic Netherlands’ website at www.dyadic.nl.

Dyadic is an early-stage biotechnology company that uses its patented and proprietary technologies to conduct research, development and commercial activities for the discovery, development, manufacture and sale of products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries. In particular, Dyadic uses its Trichoderma and C1 fungal strains in the production of its industrial enzymes. Dyadic also utilizes an integrated technology platform based on its patented and proprietary C1 fungus which enables the development and large scale manufacture of low cost proteins and enzymes for diverse market opportunities. The C1 platform technology can also be used to screen for the discovery of novel genes and proteins. Dyadic aggressively pursues licensing arrangements and other commercial opportunities to leverage the value of these technologies by providing its partners and collaborators with the benefits of manufacturing and/or utilizing the enzymes which these technologies help produce. Please visit Dyadic’s website at www.dyadic.com.

About the Kluyver Centre
The Netherlands-based Kluyver Centre for Genomics of Industrial Fermentation is one of the Centres of Excellence of the Netherlands Genomics Initiative, which pursue the highest standards in genomics research. The Kluyver Centre employs microbial genomics to improve microorganisms for use in industrial fermentation processes. Fermentation is used in the production, from renewable feedstocks, of food products and ingredients, beverages, pharmaceutical compounds, nutraceuticals, and fine and bulk chemicals. The research covers the following programmes: (1) Yeast for chemicals, fuels and beverages; (2) Filamentous fungi for proteins and peptides; (3) Lactic acid bacteria for fermented foods and food ingredients; (4) Systems biology of industrial micro-organisms; and (5) Industrial genomics for society. The Kluyver Centre is a consortium of Delft University of Technology, the universities of Groningen, Leiden and Utrecht, VU University Amsterdam, Wageningen University and Research Centre, NIZO food research and TI Food and Nutrition. Other companies represented in the Kluyver Centre’s Industrial Platform include: Applikon, Bird Engineering, FrieslandCampina, DSM, Heineken, PURAC, Danone, Tate & Lyle and Nestlé. The Kluyver Centre seeks to further expand its industrial platform with companies active in the field of industrial fermentation. Please visit the Kluyver Centre’s website at www.kluyvercentre.nl.

Cautionary Statement for Forward-Looking Statements
Certain statements contained in this press release are forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause Dyadic’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Except as required by law, Dyadic expressly disclaims any intent or obligation to update any forward-looking statements.

Contact:

Dyadic Nederland BV
Dr. Jan Wery, Science Director
Phone: +31 317 465454
Email: jwery@dyadic.nl

Kluyver Centre for Genomics of Industrial Fermentation
Prof. Han de Winde, Business Director
Phone: +31 15 2786659 / 6990
Email: j.h.dewinde@tudelft.nl



Home Contact Site Map Important Legal Notice   Search © Dyadic 2008